285 related articles for article (PubMed ID: 23448562)
1. Phakic cystoid macular edema secondary to idiopathic macular telangiectasia type 1 responsive to topical anti-inflammatory agents.
Dunn EN; Gregori NZ; Goldhardt R
Semin Ophthalmol; 2013 Mar; 28(2):84-7. PubMed ID: 23448562
[TBL] [Abstract][Full Text] [Related]
2. Ketorolac treatment of pseudophakic cystoid macular edema identified more than 24 months after cataract extraction.
Weisz JM; Bressler NM; Bressler SB; Schachat AP
Ophthalmology; 1999 Sep; 106(9):1656-9. PubMed ID: 10485530
[TBL] [Abstract][Full Text] [Related]
3. Bilateral and symmetric postoperative cystoid macular edema in a patient with macular telangiectasia type 2 after uneventful subsequent phacoemulsification procedures.
Tsaousis KT; Tsokolas G
J Cataract Refract Surg; 2019 Aug; 45(8):1195-1197. PubMed ID: 31133418
[TBL] [Abstract][Full Text] [Related]
4. Topical nepafenac as an alternate treatment for cystoid macular edema in steroid responsive patients.
Warren KA; Fox JE
Retina; 2008; 28(10):1427-34. PubMed ID: 18664937
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal analysis of the structural pattern of pseudophakic cystoid macular edema using multimodal imaging.
Sigler EJ; Randolph JC; Kiernan DF
Graefes Arch Clin Exp Ophthalmol; 2016 Jan; 254(1):43-51. PubMed ID: 25863671
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone implant for the treatment of edema related to idiopathic macular telangiectasia.
Sandali O; Akesbi J; Rodallec T; Laroche L; Nordmann JP
Can J Ophthalmol; 2013 Aug; 48(4):e78-80. PubMed ID: 23931489
[No Abstract] [Full Text] [Related]
8. Intravitreal bevacizumab for treatment of proliferative and nonproliferative type 2 idiopathic macular telangiectasia.
Roller AB; Folk JC; Patel NM; Boldt HC; Russell SR; Abramoff MD; Mahajan VB
Retina; 2011 Oct; 31(9):1848-55. PubMed ID: 21610563
[TBL] [Abstract][Full Text] [Related]
9. [Measurement of macular edema in retinal vein occlusion using optical coherence tomography and its visual prognosis].
Zhang HR; Wang X; Lu XR; Yang YF; Liu F
Zhonghua Yan Ke Za Zhi; 2005 Oct; 41(10):910-6. PubMed ID: 16271177
[TBL] [Abstract][Full Text] [Related]
10. Macular Telangiectasia Type 1 Managed With Long-Term Aflibercept Therapy.
Kovach JL; Hess H; Rosenfeld PJ
Ophthalmic Surg Lasers Imaging Retina; 2016 Jun; 47(6):593-5. PubMed ID: 27327292
[TBL] [Abstract][Full Text] [Related]
11. Rapid response of cystoid macular edema related to Nd:YAG laser capsulotomy to 0.5% ketorolac.
Lee MS; Lass JH
Ophthalmic Surg Lasers Imaging; 2004; 35(2):162-4. PubMed ID: 15088830
[TBL] [Abstract][Full Text] [Related]
12. Retinal structural alterations and macular sensitivity in idiopathic macular telangiectasia type 1.
Takayama K; Ooto S; Tamura H; Yamashiro K; Otani A; Tsujikawa A; Yoshimura N
Retina; 2012 Oct; 32(9):1973-80. PubMed ID: 22487581
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic macular telangiectasia type 2 (idiopathic juxtafoveolar retinal telangiectasis type 2A, Mac Tel 2).
Wu L; Evans T; Arevalo JF
Surv Ophthalmol; 2013; 58(6):536-59. PubMed ID: 24160729
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion.
Williamson TH; O'Donnell A
Am J Ophthalmol; 2005 May; 139(5):860-6. PubMed ID: 15860292
[TBL] [Abstract][Full Text] [Related]
15. Bilateral cystoid macular edema with giant retinal achromic patch in a patient with tuberous sclerosis.
Andrews L; Lally DR; Baumal CR
Ophthalmic Surg Lasers Imaging Retina; 2014; 45(6):602-5. PubMed ID: 25423644
[TBL] [Abstract][Full Text] [Related]
16. The Use of Topical Non-steroidal Anti-inflammatory Drugs for Uveitic Cystoid Macular Edema.
Petrushkin H; Rogers D; Pavesio C
Ocul Immunol Inflamm; 2018; 26(5):795-797. PubMed ID: 28080174
[TBL] [Abstract][Full Text] [Related]
17. THE LONG-TERM EFFECT OF CYSTOTOMY WITH FIBRINOGEN CLOT REMOVAL FOR A CYSTOID MACULAR EDEMA SECONDARY TO IDIOPATHIC MACULAR TELANGIECTASIA TYPE 1: A CASE REPORT.
Maki H; Imai H; Yamada H; Tetsumoto A; Hayashida M; Otsuka K; Miki A; Nakamura M
Retin Cases Brief Rep; 2023 Mar; 17(2):101-104. PubMed ID: 33411468
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of cystoid spaces in type 2 idiopathic macular telangiectasia on spectral domain optical coherence tomography images.
Oh JH; Oh J; Togloom A; Kim SW; Huh K
Retina; 2014 Jun; 34(6):1123-31. PubMed ID: 24240556
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cone pathologic changes in idiopathic macular telangiectasia types 1 and 2 using adaptive optics scanning laser ophthalmoscopy.
Ooto S; Hangai M; Takayama K; Ueda-Arakawa N; Tsujikawa A; Yamashiro K; Oishi A; Hanebuchi M; Yoshimura N
Am J Ophthalmol; 2013 Jun; 155(6):1045-1057.e4. PubMed ID: 23465268
[TBL] [Abstract][Full Text] [Related]
20. Optical coherence tomography of idiopathic juxtafoveolar telangiectasia.
Albini TA; Benz MS; Coffee RE; Westfall AC; Lakhanpal RR; McPherson AR; Holz ER
Ophthalmic Surg Lasers Imaging; 2006; 37(2):120-8. PubMed ID: 16583633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
